These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 2960763)

  • 21. Binding to erythrocyte complement receptor type 1 of BSA/anti-BSA complexes opsonized by C4A3 or C4B1 in the presence of serum.
    Klint C; Truedsson L; Sturfelt G
    Scand J Immunol; 1995 Oct; 42(4):425-32. PubMed ID: 7569775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune complex binding to erythrocyte-CR1 (CD 35), CR1 expression and levels of erythrocyte-fixed C3 fragments in SLE outpatients.
    Jepsen HH; Møller Rasmussen J; Teisner B; Schrøder L; Holmskov U; Jarlbaek L; Isager H; Svehag SE
    APMIS; 1990 Jul; 98(7):637-44. PubMed ID: 2144431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins.
    Klickstein LB; Wong WW; Smith JA; Weis JH; Wilson JG; Fearon DT
    J Exp Med; 1987 Apr; 165(4):1095-112. PubMed ID: 2951479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: low erythrocyte CR1 expression is an acquired phenomenon.
    Kumar A; Kumar A; Sinha S; Khandekar PS; Banerjee K; Srivastava LM
    Immunol Cell Biol; 1995 Oct; 73(5):457-62. PubMed ID: 8595925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural and functional studies on the human C3b/C4b receptor (CR1) purified by affinity chromatography using a monoclonal antibody.
    Holers VM; Seya T; Brown E; O'Shea JJ; Atkinson JP
    Complement; 1986; 3(2):63-78. PubMed ID: 2945695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypercatabolism of C3 and C4 in active and inactive systemic lupus erythematosus.
    Charlesworth JA; Peake PW; Golding J; Mackie JD; Pussell BA; Timmermans V; Wakefield D
    Ann Rheum Dis; 1989 Feb; 48(2):153-9. PubMed ID: 2784659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetohydroxamate, a urease inhibitor, inhibits the covalent binding reaction of complement proteins C3 and C4.
    Sim E; Jones A; Stanley L
    Acta Pharmacol Toxicol (Copenh); 1985 Oct; 57(4):304-6. PubMed ID: 4083040
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus.
    Garabet L; Gilboe IM; Mowinckel MC; Jacobsen AF; Mollnes TE; Sandset PM; Jacobsen EM
    Scand J Immunol; 2016 Aug; 84(2):95-9. PubMed ID: 27135178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C3b receptor (CR1) on erythrocytes in various diseases.
    Takemura S; Deguchi M; Ueda M; Yoshida N; Kato H; Yoshikawa T; Sugino S; Kondo M
    Immunol Lett; 1984; 7(6):325-8. PubMed ID: 6233222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins.
    Weis JJ; Toothaker LE; Smith JA; Weis JH; Fearon DT
    J Exp Med; 1988 Mar; 167(3):1047-66. PubMed ID: 2832506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Origin of the fourth component of complement related Chido and Rodgers blood group antigens.
    Atkinson JP; Chan AC; Karp DR; Killion CC; Brown R; Spinella D; Shreffler DC; Levine RP
    Complement; 1988; 5(2):65-76. PubMed ID: 2967744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased amounts of C4-containing immune complexes and inefficient activation of C3 and the terminal complement pathway in a patient with homozygous C2 deficiency and systemic lupus erythematosus.
    Garred P; Mollnes TE; Thorsteinsson L; Erlendsson K; Steinsson K
    Scand J Immunol; 1990 Jan; 31(1):59-64. PubMed ID: 2300790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and characterization of IgG immunoconglutinins from patients with systemic lupus erythematosus: implications for a regulatory function.
    Nilsson B; Ekdahl KN; Svarvare M; Bjelle A; Nilsson UR
    Clin Exp Immunol; 1990 Nov; 82(2):262-7. PubMed ID: 2146995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythrocytes transfused into patients with SLE and haemolytic anaemia lose complement receptor type 1 from their cell surface.
    Walport M; Ng YC; Lachmann PJ
    Clin Exp Immunol; 1987 Sep; 69(3):501-7. PubMed ID: 2959411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus.
    Holme E; Fyfe A; Zoma A; Veitch J; Hunter J; Whaley K
    Clin Exp Immunol; 1986 Jan; 63(1):41-8. PubMed ID: 2937582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased expression of C3b receptor (CR1) on erythrocytes of patients with systemic lupus erythematosus contrasts with its normal expression in other systemic diseases and does not correlate with the occurrence or severity of SLE nephritis.
    Jouvin MH; Wilson JG; Bourgeois P; Fearon DT; Kazatchkine MD
    Complement; 1986; 3(2):88-96. PubMed ID: 2945697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement-mediated solubilization of immune complexes and their interaction with complement C3 receptors.
    Petersen I; Baatrup G; Jepsen HH; Svehag SE
    Complement; 1985; 2(2-3):97-110. PubMed ID: 2935361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
    Ahearn JM; Fearon DT
    Adv Immunol; 1989; 46():183-219. PubMed ID: 2551147
    [No Abstract]   [Full Text] [Related]  

  • 39. The in vivo metabolism of the third component of complement in systemic lupus erythematosus.
    Petz LD; Powers R; Fries JR; Cooper NR; Holman HR
    Arthritis Rheum; 1977; 20(7):1304-13. PubMed ID: 303101
    [No Abstract]   [Full Text] [Related]  

  • 40. Membrane complement receptors specific for bound fragments of C3.
    Ross GD; Medof ME
    Adv Immunol; 1985; 37():217-67. PubMed ID: 3159188
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.